Chemtech Indust. (537326)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• RoCE of 14.19% suggests the company generates decent operating returns on capital employed, even in a weak year.
• P/B of 3.49 is not astronomical, though book value of ₹50.07 provides some floor if assets are sound.
• The stock is at its 52-week high, indicating market confidence that a recovery may be underway.
• As an industrial products company, it may have niche customers or contracts that support a turnaround.

Concerns

• Sales growth of -33.98% shows severe demand destruction or loss of business.
• Profit growth of -87.33% and latest quarter net profit of ₹0 Cr highlight a near-breakeven operation.
• Piotroski F-Score of 3/9 signals weak financial health and poor operational efficiency.
• No dividend yield and insufficient data on debt or promoter holding reduce transparency for minority investors.

AI Analysis

Let me look at this plainly. Chemtech Indust. has seen sales collapse by nearly 34% and profits by 87%. The latest quarter shows sales of just ₹5 Cr and net profit of about zero. That is not a business I can value with any confidence. The return on equity is only 7.01%, well below what I would want from a quality compounder. The return on capital employed is better at 14.19%, but without debt/equity or promoter holding data, I cannot judge the balance sheet or whether management thinks like owners. The Piotroski F-score of 3 out of 9 is a red flag; it suggests poor fundamentals across profitability, leverage, and efficiency. And yet the stock trades at ₹174.65, at the very top of its 52-week range, with a P/E of 18.66 on badly depressed earnings. That gives me no margin of safety. The market is pricing in a recovery that I cannot see in the numbers. Benjamin Graham taught me to focus on facts and insist on a price well below intrinsic value. Here I have falling sales, negligible profits, no dividend, and insufficient disclosure. This is not a stalwart. It may be a turnaround candidate, but I would need several quarters of improving results and a much lower price before I would even consider investing. Patience and discipline, not hope, are the keys.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer